छोड़कर सामग्री पर जाएँ

Strides Pharma sinks after subsidiary plans to divest manufacturing plant

The manufacturing unit has a potential for future expansion up to a further 20,000 litres of biologics drug substance manufacturing capacity.

Read More

​ The manufacturing unit has a potential for future expansion up to a further 20,000 litres of biologics drug substance manufacturing capacity. The manufacturing unit has a potential for future expansion up to a further 20,000 litres of biologics drug substance manufacturing capacity.  Moneycontrol Latest News Read More  

Top 100 Best Sellers

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी
en_USEnglish hi_INहिन्दी